Literature DB >> 12200630

Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.

Masashi Mizuguchi1, Hideo Yamanouchi, Laurence E Becker, Masayuki Itoh, Sachio Takashima.   

Abstract

Cerebral cortical lesions of tuberous sclerosis (TSC) and focal cortical dysplasia (FCD) show disturbances in laminar architecture and cellular differentiation. We immunohistochemically studied the expression of doublecortin, a fetal neuronal protein that regulates neuronal migration, in the surgical specimens of five TSC and eight FCD patients. In both TSC and FCD, bizarre giant cells showed a variable degree of doublecortin immunoreactivity. Both cytomegalic neurons and balloon cells were positive. The staining tended to be more intense in TSC than in FCD, although there were exceptional cases in both groups. Doublecortin immunoreactivity of normal-sized neural cells was restricted to a small number of astrocytes, and comparable to that in control patients. The persistent expression of doublecortin by giant cells in the postnatal cerebrum is additional evidence of abnormal differentiation, which may be relevant to the pathogenesis of cortical disarray in TSC and FCD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200630     DOI: 10.1007/s00401-002-0575-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias.

Authors:  Ksenia A Orlova; Victoria Tsai; Marianna Baybis; Gregory G Heuer; Sanjay Sisodiya; Maria Thom; Kevin Strauss; Eleonora Aronica; Phillip B Storm; Peter B Crino
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

Review 2.  Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.

Authors:  Michael Wong
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

Review 3.  Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.

Authors:  Sara Abdijadid; Gary W Mathern; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243

Review 4.  Giant cells: contradiction to two-hit model of tuber formation?

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

Review 5.  The tuberous sclerosis complex.

Authors:  Ksenia A Orlova; Peter B Crino
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 6.  Cortical dysplasia: neuropathological aspects.

Authors:  Christian H Rickert
Journal:  Childs Nerv Syst       Date:  2006-06-09       Impact factor: 1.475

Review 7.  Giant cells: contradiction to two-hit model of tuber formation?

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak
Journal:  Cell Mol Neurobiol       Date:  2006-08-09       Impact factor: 4.231

8.  Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.

Authors:  Song Li; Zhenle Zang; Jiaojiang He; Xin Chen; Sixun Yu; Yuchun Pei; Zhi Hou; Ning An; Hui Yang; Chunqing Zhang; Shiyong Liu
Journal:  Oncotarget       Date:  2017-01-24

9.  Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia.

Authors:  Viera Kútna; Libor Uttl; Robert Waltereit; Zdenka Krištofiková; Daniel Kaping; Tomáš Petrásek; Cyril Hoschl; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

Review 10.  Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment.

Authors:  Masashi Mizuguchi; Maki Ohsawa; Hirofumi Kashii; Atsushi Sato
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.